ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-17A and IL-12/23 Targeted Therapies for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons
Nov 18, 2024, 10:30 AM
«
2921
2922
2923
2924
2925
2926
2927
2928
2929
(current)
2930
»